ZYUS Life Sciences Corporation (TSXV:ZYUS)
0.6500
+0.0400 (6.56%)
Sep 29, 2025, 1:20 PM EDT
ZYUS Life Sciences Revenue
ZYUS Life Sciences had revenue of 120.00K CAD in the quarter ending June 30, 2025, with 1.69% growth. This brings the company's revenue in the last twelve months to 483.00K, up 12.85% year-over-year. In the year 2024, ZYUS Life Sciences had annual revenue of 481.00K with 37.04% growth.
Revenue (ttm)
483.00K
Revenue Growth
+12.85%
P/S Ratio
105.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.80M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 481.00K | 130.00K | 37.04% |
Dec 31, 2023 | 351.00K | 53.00K | 17.79% |
Dec 31, 2022 | 298.00K | 91.00K | 43.96% |
Dec 31, 2021 | 207.00K | - | - |
Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Curaleaf Holdings | 1.75B |
Green Thumb Industries | 1.57B |
dentalcorp Holdings | 1.62B |
Trulieve Cannabis | 1.62B |
Sienna Senior Living | 929.68M |
Cronos Group | 177.69M |
WELL Health Technologies | 1.12B |
Extendicare | 1.51B |